MeSH term
Frequency | Condition_Probility | Autistic Disorder/*genetics | 8 | 13.0 |
Chromosomes, Human, Pair 15/*genetics | 9 | 9.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
Genotype | 13 | 0.0 |
Humans | 75 | 0.0 |
Linkage Disequilibrium | 4 | 0.0 |
Polymorphism, Single Nucleotide | 3 | 0.0 |
Receptors, GABA-A/*genetics | 26 | 34.0 |
Research Support, Non-U.S. Gov't | 48 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 31 | 0.0 |
Adolescent | 17 | 0.0 |
Alleles | 14 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Child | 24 | 0.0 |
DNA/genetics | 2 | 0.0 |
English Abstract | 4 | 0.0 |
Epilepsy, Absence/*genetics | 5 | 29.0 |
Female | 45 | 0.0 |
Gene Frequency | 5 | 0.0 |
*Linkage Disequilibrium | 6 | 3.0 |
Male | 47 | 0.0 |
Microsatellite Repeats | 5 | 0.0 |
Receptors, GABA-B/*genetics | 4 | 36.0 |
Base Sequence | 16 | 0.0 |
Chromosome Mapping | 24 | 0.0 |
Family Health | 3 | 0.0 |
Haplotypes | 2 | 0.0 |
Protein Subunits/genetics | 2 | 7.0 |
*Chromosomes, Human, Pair 15 | 29 | 13.0 |
Family | 2 | 0.0 |
Genetic Markers | 15 | 0.0 |
*Polymorphism, Genetic | 5 | 0.0 |
Lod Score | 3 | 0.0 |
Pedigree | 12 | 0.0 |
Heterozygote Detection | 2 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
Molecular Sequence Data | 16 | 0.0 |
Polymerase Chain Reaction | 11 | 0.0 |
Receptors, GABA/*genetics | 5 | 45.0 |
Angelman Syndrome/*diagnosis/genetics | 3 | 37.0 |
DNA Primers | 2 | 0.0 |
*Gene Deletion | 3 | 0.0 |
In Situ Hybridization, Fluorescence | 15 | 0.0 |
Prader-Willi Syndrome/*diagnosis/genetics | 2 | 25.0 |
Dinucleotide Repeats | 3 | 3.0 |
Genetic Predisposition to Disease/genetics | 3 | 0.0 |
Middle Aged | 6 | 0.0 |
Polymorphism, Genetic | 7 | 0.0 |
Angelman Syndrome/*genetics | 15 | 30.0 |
Chromosome Deletion | 6 | 0.0 |
Chromosomes, Human, Pair 15/genetics | 4 | 5.0 |
DNA Mutational Analysis | 4 | 0.0 |
Protein Subunits | 2 | 0.0 |
Receptors, GABA-A/genetics | 6 | 46.0 |
Sequence Deletion | 7 | 0.0 |
Ubiquitin-Protein Ligases | 4 | 1.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Receptors, Dopamine D2/*genetics | 2 | 0.0 |
Animals | 14 | 0.0 |
Chromosome Banding | 9 | 1.0 |
DNA Methylation | 4 | 0.0 |
Karyotyping | 6 | 0.0 |
*Translocation, Genetic | 3 | 0.0 |
Adult | 19 | 0.0 |
Child, Preschool | 14 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Infant | 8 | 0.0 |
Infant, Newborn | 3 | 0.0 |
Polymorphism, Restriction Fragment Length | 5 | 0.0 |
Receptors, GABA/genetics | 3 | 37.0 |
Syndrome | 4 | 0.0 |
Autoantigens/*genetics | 2 | 2.0 |
*Chromosome Deletion | 8 | 1.0 |
Genomic Imprinting | 3 | 1.0 |
Prader-Willi Syndrome/*genetics | 14 | 17.0 |
*Ribonucleoproteins, Small Nuclear | 2 | 3.0 |
Chromosomes, Human, Pair 15 | 9 | 7.0 |
DNA Replication/*genetics | 2 | 3.0 |
S Phase/genetics | 2 | 9.0 |
*Chromosome Mapping | 2 | 0.0 |
Electrophoresis, Gel, Pulsed-Field | 2 | 0.0 |
Genomic Library | 2 | 0.0 |
Restriction Mapping | 5 | 0.0 |
Angelman Syndrome/*genetics/physiopathology | 3 | 100.0 |
*Disease Models, Animal | 3 | 0.0 |
Mice | 10 | 0.0 |
Electroencephalography | 4 | 1.0 |
Prader-Willi Syndrome/genetics | 4 | 19.0 |
*Chromosomes, Human, Pair 14 | 2 | 1.0 |
*Linkage (Genetics) | 2 | 0.0 |
Models, Genetic | 3 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
Angelman Syndrome/*genetics/pathology | 2 | 40.0 |
*Genomic Imprinting | 5 | 1.0 |
Translocation, Genetic | 3 | 0.0 |
Age Factors | 2 | 0.0 |
Epilepsy/*genetics/physiopathology | 2 | 25.0 |
Phenotype | 11 | 0.0 |
Chromosome Disorders | 3 | 0.0 |
*Chromosome Aberrations | 2 | 0.0 |
Ligases/genetics | 2 | 5.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 6 | 0.0 |
Blotting, Southern | 5 | 0.0 |
*Inversion, Chromosome | 2 | 2.0 |
Cells, Cultured | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Exons | 2 | 0.0 |
*Multigene Family | 4 | 0.0 |
Protein Conformation | 2 | 0.0 |
Receptors, GABA-A/chemistry/*genetics | 3 | 42.0 |
DNA | 3 | 0.0 |
*Microsatellite Repeats | 2 | 0.0 |
Rats | 2 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Cell Line | 4 | 0.0 |
Evoked Potentials, Motor | 2 | 22.0 |
Gene Deletion | 3 | 0.0 |
Recombination, Genetic | 2 | 0.0 |
Methylation | 2 | 0.0 |
DNA Probes | 3 | 0.0 |
DNA, Satellite/genetics | 2 | 1.0 |
In Situ Hybridization, Fluorescence/*methods | 2 | 2.0 |
Comparative Study | 7 | 0.0 |
Gene Expression | 2 | 0.0 |
*Genes, Structural | 2 | 0.0 |
*Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Homozygote | 2 | 0.0 |
Mice, Mutant Strains | 3 | 0.0 |
Parents | 2 | 2.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Genome, Human | 3 | 0.0 |
Macromolecular Substances | 2 | 0.0 |
Oligodeoxyribonucleotides | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Angelman Syndrome/diagnosis/*genetics | 2 | 40.0 |
Gene Library | 2 | 0.0 |
Prader-Willi Syndrome/diagnosis/*genetics | 2 | 66.0 |
DNA/blood/genetics/isolation & purification | 2 | 5.0 |
Lymphocytes/physiology | 2 | 2.0 |
Polymerase Chain Reaction/methods | 3 | 0.0 |
